Renal Denervation

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual me...

Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 

SYMPLICITY HTN-3 TRial, ACC.14, renal denervation

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial. This trial data was presented to a packed, standing-r...

renal denervation

One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat pharmacologically uncontrolled hypertension. It is estimated there are more than 10 million drug-resistant hypertension patients...

Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled...
Renal denervation, hypertension, Peregrine System
Ablative Solutions Inc. announced the addition of Michael Weber, M.D., FACP, FACC, FAHA, to its Scientific Advisory Board. 
VIVA Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announced late-breaking clinical trial results VIVA 14...
Twelve-month Data St. Jude Medical EnligHTN Renal Denervation System
St. Jude Medical Inc. announced 12-month outcome data from the EnligHTN III study, which demonstrated a continuation of safe, rapid and effective treatment...

Articles

Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled...
July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t...
Journal of Endovascular Therapy Hypertension Renal Denervation Therapy
Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 
Medtronic, SYMPLICITY, SYMPLICITY HTN-3 trial, renal denervation, ACC.14
A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
1 day 22 hours ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
4 weeks 1 day ago
It’s been no secret that the American healthcare system needed to change to survive economically...
10 weeks 2 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available